AUM Pharmacy
Health Hub
Search Icon

AUM Pharmacy

Hi there!

Hello, Login
All Categories
VisaVisaVisa
fallback

Dibotab M 50mg/500mg Tablet

Prescription Icon
Prescription Required

Marketer

HiGlance Laboratories

Salt Composition

Sitagliptin (50mg) + Metformin (500mg)

Overview Dibotab M 50mg/500mg Tablet

Glycemic control in type 2 diabetes mellitus is achieved with Metformin/Glibenclamide 50mg/500mg tablets, a dual-action formulation. This medication mitigates diabetes-related complications like renal impairment and visual disturbances, potentially lowering cardiovascular event risk. It may be used as monotherapy or in conjunction with other antidiabetic agents, its efficacy maximized by adherence to a healthy lifestyle including diet and exercise. Dosage is individualized based on your health status, glycemic readings, and concurrent medications. Ingestion with food minimizes gastrointestinal discomfort. Consistent, daily administration at the same time is crucial for optimal results; discontinuation should only occur under medical supervision. Continued commitment to your doctor's prescribed diet and exercise plan is essential. Lifestyle choices significantly influence diabetes management. Commonly reported adverse effects include nausea, vomiting, diarrhea, stomach upset, headache, and pharyngitis. Hypoglycemia, a possible side effect when used with insulin or sulfonylureas, necessitates awareness of its symptoms and management. This medication is not universally appropriate. Prior medical history, including kidney, liver, or heart conditions, pancreatic disorders, and alcohol consumption should be disclosed to your physician before initiating treatment. Pregnant or lactating individuals require medical consultation before use. Potential drug interactions necessitate a comprehensive review of all medications with your doctor to ensure safety. Alcohol should be avoided due to its hypoglycemic effect. Kidney function and blood glucose levels will be monitored regularly by your physician throughout treatment.

Uses of Dibotab M 50mg/500mg Tablet

Managing type 2 diabetes

Major Benefits of Dibotab M 50mg/500mg Tablet:

Consume this medication precisely as prescribed by your physician, adhering to both the dosage and treatment length. Ingest the tablet whole; avoid chewing, crushing, or fracturing it. It's recommended to take the Dibotab M 50mg/500mg Tablet with a meal.

Common Side effects of Dibotab M 50mg/500mg Tablet:

  • Decreased appetite
  • Vomiting
  • Upper respiratory tract infection
  • Hypoglycemia (low blood glucose level)
  • Abdominal bloating
  • Nausea
  • Diarrhea

How to use Dibotab M 50mg/500mg Tablet:

Consume this medication precisely as directed by your physician, adhering to the prescribed dosage and timeframe. Ingest the tablet whole; avoid chewing, crushing, or fracturing it. The Dibotab M 50mg/500mg tablet should be administered with a meal.

How Dibotab M 50mg/500mg Tablet works:

Dibotab M, a 50mg/500mg tablet, combines sitagliptin and metformin to manage blood glucose. Sitagliptin enhances insulin production by the pancreas, improves insulin utilization, and decreases hepatic glucose output. Metformin, a biguanide, reduces liver glucose production, slows intestinal glucose absorption, and increases insulin sensitivity. This dual action leads to superior glycemic control.

SAFETY ADVICE

AlcoholAlcoholUNSAFE

Consuming alcohol alongside Dibotab M 50mg/500mg Tablet is inadvisable.

PregnancyPregnancyCONSULT YOUR DOCTOR

The use of Dibotab M 50mg/500mg tablets during pregnancy may pose risks. While human data is scarce, animal research indicates potential harm to the unborn child. A physician will assess the potential advantages against the risks prior to any prescription. Seek medical advice.

Breast feedingBreast feedingCONSULT YOUR DOCTOR

Nursing mothers should likely avoid Dibotab M 50mg/500mg tablets. Preliminary research indicates potential transfer to breast milk, posing a possible risk to the infant.

DrivingDrivingCAUTION

Driving may be impaired if your blood glucose levels are abnormally low or elevated. Refrain from driving if such symptoms arise.

KidneyKidneyCAUTION

Caution is advised when administering Dibotab M 50mg/500mg tablets to individuals with impaired renal function; dosage modification may be necessary. Consultation with a physician is recommended. Dibotab M 50mg/500mg tablets are contraindicated in patients exhibiting severe kidney disease. Routine monitoring of kidney function is prudent during treatment.

LiverLiverUNSAFE

Use of Dibotab M 50mg/500mg tablets in individuals with hepatic impairment is likely inadvisable and should be avoided. Physician consultation is recommended.

What if you forget to take Dibotab M 50mg/500mg Tablet :

Should you forget a Dibotab M 50mg/500mg Tablet dose, administer it immediately. Nevertheless, if your next scheduled dose is imminent, omit the missed dose and resume your usual dosing regimen. Avoid taking a double dose.

Facts to Know About Dibotab M 50mg/500mg Tablet

LabelValue
Developing Habits No.
Treatment Category Diabetes Management

FAQs on Dibotab M 50mg/500mg Tablet

Dibotab M 50mg/500mg tablets combine sitagliptin and metformin to manage type 2 diabetes in adults. This medication helps control blood sugar when used with a healthy diet and exercise. Metformin reduces liver glucose production and enhances insulin sensitivity, while sitagliptin boosts insulin release by inhibiting DPP-4. It's not suitable for individuals under 18.
Prolonged use of Dibotab M 50mg/500mg tablets can lead to vitamin B12 deficiency by hindering its absorption. This deficiency may cause anemia, nerve damage (manifesting as tingling, numbness in extremities, weakness, and urinary issues), and cognitive changes (including balance problems). To mitigate these risks, annual supplemental vitamin B12 is recommended by some researchers.
Dibotab M 50mg/500mg tablets may cause common side effects including hypoglycemia, altered taste, nausea, stomach pain, diarrhea, headache, and upper respiratory infections. Rare but serious side effects such as lactic acidosis are also possible. Prolonged use may result in vitamin B12 deficiency.
Dibotab M 50mg/500mg Tablets are contraindicated in patients with known allergies to its components or excipients, and in those with severe kidney or liver impairment, congestive heart failure, lactic acidosis, or diabetic ketoacidosis.
Combining Dibotab M 50mg/500mg tablets with alcohol is unsafe and may heighten the risk of lactic acidosis.
Store this medication in its original, tightly closed container, following the storage instructions on the label. Discard any unused medication and keep it out of reach of children, pets, and others.
Dibotab M 50mg/500mg (containing metformin) can cause lactic acidosis, a serious medical emergency characterized by high blood lactic acid levels (also known as MALA). This rare side effect necessitates caution in patients with kidney disease, the elderly, or those who consume excessive alcohol. Symptoms include muscle pain/weakness, dizziness, fatigue, cold extremities, shortness of breath, nausea, vomiting, abdominal pain, and bradycardia. If these occur, discontinue Sitagliptin + Metformin and seek immediate medical attention.
Dibotab M 50mg/500mg tablets combine sitagliptin and metformin to manage type 2 diabetes in adults. This combination improves blood sugar control when used with diet and exercise. Metformin reduces liver glucose production and enhances insulin sensitivity, while sitagliptin increases insulin release by inhibiting DPP-4. It's not suitable for individuals under 18.
Dibotab M 50mg/500mg tablets may cause common side effects such as hypoglycemia, altered taste, nausea, stomach pain, diarrhea, headache, and upper respiratory infections. Rare but serious side effects include lactic acidosis. Prolonged use can also result in vitamin B12 deficiency.
Dibotab M 50mg/500mg Tablets are contraindicated in patients with known allergies to any ingredient or excipient. Avoid use in patients with severe kidney or liver impairment, congestive heart failure, lactic acidosis, or diabetic ketoacidosis.
Combining Dibotab M 50mg/500mg tablets with alcohol is unsafe and may heighten the risk of lactic acidosis.
Dibotab M 50mg/500mg (containing metformin) can cause lactic acidosis, a serious medical emergency characterized by high blood lactic acid levels (also known as MALA – Metformin-associated lactic acidosis). This rare side effect necessitates caution in patients with kidney disease, the elderly, or those who consume excessive alcohol. Symptoms include muscle pain/weakness, dizziness, fatigue, cold extremities, shortness of breath, nausea, vomiting, abdominal pain, and bradycardia. If these occur, discontinue Sitagliptin + Metformin and seek immediate medical attention.
Prolonged use of Dibotab M 50mg/500mg tablets can lead to vitamin B12 deficiency by impairing its absorption. This deficiency may cause anemia, nerve damage (manifesting as tingling, numbness in extremities, weakness, and balance problems), and urinary issues, along with potential cognitive changes. To mitigate these risks, yearly supplemental vitamin B12 is recommended by some researchers.
Store this medication in its original, tightly closed container, following the storage instructions on the label. Discard any unused medication and keep it out of reach of children, pets, and others.
Dibotab M 50mg/500mg tablets combine sitagliptin and metformin to treat type 2 diabetes in adults. This medication improves blood sugar control when used with diet and exercise. Metformin reduces liver glucose production and enhances insulin sensitivity, while sitagliptin increases insulin release by inhibiting DPP-4. It's not suitable for individuals under 18.
Dibotab M 50mg/500mg tablets may cause common side effects such as hypoglycemia, altered taste, nausea, stomach pain, diarrhea, headache, and upper respiratory tract infections. Rare but serious side effects include lactic acidosis. Prolonged use may also result in vitamin B12 deficiency.
Dibotab M 50mg/500mg Tablets are contraindicated in patients with known allergies to any ingredient. Avoid use in patients with severe kidney or liver impairment, congestive heart failure, lactic acidosis, or diabetic ketoacidosis.
Combining Dibotab M 50mg/500mg tablets with alcohol is unsafe and may raise your risk of lactic acidosis.
Dibotab M 50mg/500mg (containing metformin) can cause lactic acidosis (MALA), a serious medical emergency resulting from excessive blood lactic acid. This rare side effect necessitates avoiding Dibotab M in patients with kidney disease, the elderly, or those who consume significant alcohol. Symptoms include muscle pain/weakness, dizziness, fatigue, cold extremities, shortness of breath, nausea/vomiting, abdominal pain, and bradycardia. If these occur, discontinue Dibotab M and seek immediate medical attention.
Prolonged Dibotab M 50mg/500mg Tablet use can lead to vitamin B12 deficiency by hindering its absorption. This deficiency, if left untreated, may cause anemia, nerve damage (manifested as tingling, numbness in extremities, weakness, and balance problems), urinary issues, and cognitive changes. To mitigate this risk, annual supplemental vitamin B12 is recommended by some researchers.
Store this medication in its original, tightly closed container, following the storage instructions on the label. Dispose of any unused medication safely and prevent access by children, pets, and others.
Dibotab M 50mg/500mg Tabl...
108
MRP 125
13% off